World-first experimental cancer treatment paves way for clinical trial

A groundbreaking experimental treatment using triple immunotherapy before surgery shows promising results for glioblastoma patients. Prof Long successfully adapted melanoma treatment methods to combat this aggressive brain cancer, leading to positive immune responses and no cancer recurrence after 18 months in the initial patient.